INVESTIGATIONAL ONCE-WEEKLY ORAL HIV TREATMENT REGIMEN OF ISLATRAVIR AND LENACAPAVIR MAINTAINED VIROLOGICAL SUPPRESSION IN ADULTS WITH HIV WHO SWITCHED ANTIRETROVIRAL THERAPY

Reuters · 2d ago

Please log in to view news